Enhertu--trastuzumab deruxtecan, which it is jointly developing and commercializing with Daiichi Sankyo--had met prespecified criteria for objective response...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






